Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study
- PMID: 14972472
- DOI: 10.1016/j.urology.2003.09.036
Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study
Abstract
Objectives: To describe the use of complementary and alternative medicines (CAMs) among men with a family history of prostate cancer and to evaluate the relationship between selected sociodemographic and behavioral characteristics and the use of CAMs.
Methods: Unaffected brothers of men diagnosed with prostate cancer were asked to participate in a short computer-assisted telephone interview. The survey focused primarily on the use of different vitamins, herbal supplements, and medications, some of which are marketed for prostate health or prostate cancer prevention.
Results: A total of 111 men completed the survey, representing 66% of eligible study subjects. Of the 111 men, 61 (55%) reported currently taking some form of CAM, with 30% taking a vitamin or supplement purported to have prostate-specific benefits. The prevalence of CAM use generally increased with increasing age; however, men who were younger than their affected brother at the time of the diagnosis of prostate cancer were more likely to use CAMs than were older brothers.
Conclusions: Most men with a family history of prostate cancer take vitamins and supplements, some of which are believed to prevent future cancer occurrence. The results of this study and others provide some insight into the determinants of potentially beneficial health behaviors in high-risk individuals.
Similar articles
-
Herbal and vitamin supplement use in a prostate cancer screening population.Urology. 2004 Feb;63(2):288-92. doi: 10.1016/j.urology.2003.09.019. Urology. 2004. PMID: 14972473
-
Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer.BJU Int. 2004 May;93(7):955-60. doi: 10.1111/j.1464-410X.2004.04759.x. BJU Int. 2004. PMID: 15142142
-
Risk perception and concern among brothers of men with prostate carcinoma.Cancer. 2004 Apr 1;100(7):1537-44. doi: 10.1002/cncr.20121. Cancer. 2004. PMID: 15042690
-
Critical review of complementary therapies for prostate cancer.J Clin Oncol. 2003 Jun 1;21(11):2199-210. doi: 10.1200/JCO.2003.08.083. J Clin Oncol. 2003. PMID: 12775747 Review.
-
Nontraditional treatments for localized prostate cancer: ten rules to know before talking to my patients.Semin Urol Oncol. 1999 May;17(2):64-9. Semin Urol Oncol. 1999. PMID: 10332918 Review.
Cited by
-
Use of complementary and alternative medicine before and after organ removal due to urologic cancer.Patient Prefer Adherence. 2015 Oct 1;9:1407-12. doi: 10.2147/PPA.S90061. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26491269 Free PMC article.
-
Are We Sentenced to Pharmacotherapy? Promising Role of Lycopene and Vitamin A in Benign Urologic Conditions.Nutrients. 2022 Feb 18;14(4):859. doi: 10.3390/nu14040859. Nutrients. 2022. PMID: 35215508 Free PMC article. Review.
-
Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.Urology. 2014 Jun;83(6):1356-61. doi: 10.1016/j.urology.2014.02.015. Epub 2014 Apr 16. Urology. 2014. PMID: 24745796 Free PMC article.
-
Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County study.Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3588-92. doi: 10.1158/1055-9965.EPI-08-0050. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 19064575 Free PMC article.
-
Lycopene for the prevention of prostate cancer.Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD008007. doi: 10.1002/14651858.CD008007.pub2. Cochrane Database Syst Rev. 2011. PMID: 22071840 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical